NCT03174379

Brief Summary

The purpose of this two-center study is to examine the effectiveness of acupuncture treatments in addressing mobility deficits, sensorimotor impairment, and quality of life (QOL) limitations in persons with Multiple Sclerosis (MS). It is hypothesized that acupuncture will result in an improvement in these limitations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 2, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

June 5, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 6, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2019

Completed
Last Updated

March 21, 2022

Status Verified

March 1, 2022

Enrollment Period

2 years

First QC Date

May 31, 2017

Last Update Submit

March 7, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • fatigue severity scale

    The Fatigue Severity Scale (FSS) is a method of evaluating the impact of fatigue. The FSS is a short questionnaire that requires patient to rate level of fatigue.

    14 Weeks

  • Medical Outcomes Study Pain Effects Scale

    The MOS covers pain severity in terms of intensity, frequency, and duration while recording the impact on behaviours and moods. MOS contains twelve self report items on the severity of pain over the past four weeks and its effect on mood and behaviours

    14 Weeks

  • Gait measured by 6-minute walk test

    Assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance

    14 Weeks

  • Balance measured by 25-foot walk test

    The T25-FW is a quantitative mobility and leg function performance test based on a timed 25-walk.

    14 Weeks

Study Arms (2)

Control Group

PLACEBO COMPARATOR

Standard of Care (SOC) treatment will be based upon Traditional Chinese Medicine (TCM) interpretation of 4 phases of MS.

Procedure: Standard of Care with no acupuncture

Treatment Group

ACTIVE COMPARATOR

60-minute treatment session twice a week for three weeks

Procedure: Acupuncture

Interventions

The control group will lie on a treatment table in the acupuncturist's office for the same amount of time that the treatment group did, but receive no acupuncture

Control Group
AcupuncturePROCEDURE

The first set consists of core point selection, used in an MS Standard of Care (SOC). The second set of points will be individualized to the patient's needs as determined by the acupuncturist. SOC treatment will be based upon Traditional Chinese Medicine (TCM) interpretation of 4 phases of MS.

Treatment Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of MS
  • ability to walk unaided for 6 minutes with or without assistive device

You may not qualify if:

  • bleeding precautions
  • trypanophobia
  • inability to lie still for 30 minutes
  • active cancer, current exacerbation, and history of previous acupuncture treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Standard of CareAcupuncture Therapy

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationComplementary TherapiesTherapeutics

Study Officials

  • Barbara Siminovich-blok

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2017

First Posted

June 2, 2017

Study Start

June 5, 2017

Primary Completion

June 6, 2019

Study Completion

June 6, 2019

Last Updated

March 21, 2022

Record last verified: 2022-03

Locations